Skip to content

A randomized, controlled, patient- and assessor- blinded, exploratory clinical trial to search the stimulation site for repetitive transcranial magnetic stimulation (rTMS) that improves upper extremity function after stroke

A randomized, controlled, patient- and assessor- blinded, exploratory clinical trial to search the stimulation site for repetitive transcranial magnetic stimulation (rTMS) that improves upper extremity function after stroke

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0008496
Enrollment
15
Registered
2023-06-02
Start date
2022-07-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : 1. shame control - Perform 10 simulated repetitive transcranial magnetic stimulation. (Actual stimulation is not applied in Sound Mode, and treatment is performed for 20 minutes like

Sponsors

Ministry of Science and ICT
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adults over 20 years of age 2) Patients more than 3 months after onset of stroke 3) Patients with NIHSS score of 1 or more to 20 or less 4) After receiving a detailed explanation of the study and fully understanding it, the subject has voluntarily decided to participate and has given written consent to comply with the precautions.

Exclusion criteria

Exclusion criteria: 1) Patients with systemic infectious symptoms at the time of participation in clinical trials 2) In the case of a person with impaired consent (less than 10 points on the MMSE), who is not accompanied by a guardian 3) Those with severe medical conditions such as cardiovascular system, digestive system, respiratory system, endocrine system, etc. 4) Other cases where the researcher judges that participation in this clinical trial is not appropriate 5) Those who are contraindicated for repetitive transcranial magnetic stimulation A. In the case of metal substances (deep brain stimulation electrodes, cerebral aneurysm clips, cardiac pacemakers, etc.) B. Patients with uncontrolled epilepsy (epilepsy) or mental illness 6) Pregnant, lactating women and patients who may become pregnant 7) Patients with contraindications to imaging 8) Those who have undergone cerebral surgery with past or current medical history

Design outcomes

Primary

MeasureTime frame
Comparison between the two groups of FMA (Fugl-Meyer Assessment) change values 3 months after rTMS compared to the initial test

Secondary

MeasureTime frame
Comparison of the change values of the two groups after 3 months of rTMS compared to the initial test - Comparison List: ROM (Range of Motion), BBS (Berg Balance Scale), MAS (Motor Assessment Scale), TIS (Tremble Imbalance Scale), FAC (Functional Gait Category), TUG (Time Up and Go), MMT (Passive Strength) test), ARAT(Action Reach Arm Test), Jebsen Taylor hand function test, FIM(Functional Independence Measure), MBI(Modified Barthel index), NIHSS(NIHSS(National Institutes of Health stroke scale)), K-MMSE(Korean Mini -Mental State Examination) ), CDR (Clinical Dementia Grade), GDS (Global Deterioration Scale), GDS Depression (Geriatric Depression Scale), Brain fMRI [Examination Group B patients only], EEG, Evoked Potential Test, MI Hematology Motricity index

Countries

Korea, Republic of

Contacts

Public ContactMi Jin Park

Bundang CHA General Hospital

parkmijin@chamc.co.kr+82-31-780-2954

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jul 3, 2026